Rheb activation disrupts spine synapse formation through accumulation of syntenin in tuberous sclerosis complex

Hiroko Sugiura1, Shin Yasuda1, Shutaro Katsurabayashi2

  • 1Neural Plasticity Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.

Nature Communications
|April 17, 2015
PubMed

Insights

Tuberous sclerosis complex (TSC) neurons have higher syntenin levels, disrupting synapse formation. Reducing syntenin in TSC neurons restores normal synapse densities, suggesting Rheb-syntenin signaling as a therapeutic target.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Tuberous sclerosis complex (TSC) is caused by mutations in TSC1/TSC2, affecting Rheb GTPase activity.
  • Previous studies showed impaired spine synapse morphogenesis in TSC neurons, independent of mTORC1.
  • Rheb (Ras homolog enriched in brain) is a small GTP-binding protein crucial for cellular signaling.

Purpose of the Study:

  • To investigate the role of Rheb and its interacting proteins in TSC-related synaptic abnormalities.
  • To elucidate the mechanism by which TSC mutations lead to altered synapse formation.
  • To identify potential therapeutic targets for TSC neurological complications.

Main Methods:

  • Co-immunoprecipitation to assess protein-protein interactions.
  • Western blotting to quantify protein levels in wild-type and TSC neurons.
  • Proteasomal degradation assays.
  • Immunofluorescence microscopy to analyze synapse morphology and density.

Main Results:

  • The PDZ protein syntenin preferentially binds to the GDP-bound form of Rheb.
  • Syntenin levels are elevated in TSC neurons due to impaired proteasomal degradation of the Rheb-GDP-syntenin complex.
  • Accumulated syntenin inhibits spine synapse formation by disrupting the syndecan-2/CSK interaction.
  • Syntenin promotes excitatory shaft synapse formation via interaction with ephrinB3.
  • Downregulation of syntenin in TSC neurons normalized both spine and shaft synapse densities.

Conclusions:

  • Rheb-syntenin signaling pathway is implicated in synaptic dysregulation in TSC.
  • Altered Rheb-GDP-syntenin complex formation and subsequent syntenin accumulation contribute to synaptic defects in TSC neurons.
  • Targeting the Rheb-syntenin pathway offers a potential therapeutic strategy for TSC-associated synaptic abnormalities.

Related Concept Videos

Rab Cascades01:25

Rab Cascades

Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
3.8K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
89.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
21.2K
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
5.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K